Drug intelligence / Profile preview

Populus alba pollen

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intradermal, Percutaneous, Sublingual
01

Overview

Populus alba pollen is an allergenic extract derived from the pollen of the Populus alba plant, also known as the white poplar tree. It is a biological product used for both diagnostic and therapeutic purposes in individuals with allergies to tree pollens. For diagnosis, it is used in allergy skin tests. As a therapy, it is administered via immunotherapy (hyposensitization) to gradually build tolerance to the allergen, thereby reducing the allergic response. The product is available as a non-standardized injectable solution and is marketed by several companies, including ALK-Abello and Greer Laboratories. It has been in use since 1965 for patients with immediate hypersensitivity to white poplar pollen and related allergens. [1, 2]

Other names
white poplar pollen extractwhite poplar pollensilver-leaf poplar pollen
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Populus alba pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Populus alba pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call